Skip to ContentSkip to Navigation
Research ENTEG News overview

Promising UG researcher goes to US on Rubicon grant

22 January 2024

PhD graduate Wenjian Li from the University of Groningen will be able to conduct research at the California Institute of Technology for two years thanks to the Rubicon programme organized by the Netherlands Organisation for Scientific Research (NWO) and ZorgOnderzoek Nederland Medische Wetenschappen (ZonMw; Healthcare Research Dutch Medical Sciences) . The NWO and ZonMw Rubicon programme enables talented, young researchers to acquire international research experience to help kick-start their academic careers.

Li's research concerns catching external body motions for inspecting internal body biomarkers.
Wearable sweat biosensors can non‐invasively monitor metabolic biomarkers. However, their analysis accuracy is affected by body activities and they use rigid and bulky batteries, posing inconvenience and safety concerns. The researchers will create battery‐free wearable sweat biosensors with body motion recognition and body motion energy harvesting via the triboelectric effect.

Wenjian Li obtained his PhD cum laude from ENTEG , the Groningen Engineering and Technology Institute at the University of Groningen (UG).

Last modified:24 January 2024 2.21 p.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 17 July 2025

    Veni-grants for eleven UG researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...

  • 14 July 2025

    ERC Proof of Concept grant for Kottapalli and Covi

    Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).

  • 10 July 2025

    Dutch Research Agenda funding for nanomedicine research

    Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.